Brief: Spectrum Pharmaceuticals Announces Presentation Of Poziotinib In Combination With Krasg12c Inhibitors At The 2021 Aacr-Nci-Eortc Conference
07/10/2021 14:12
Oct 7 (Reuters) - Spectrum Pharmaceuticals Inc SPPI.O :
* SPECTRUM PHARMACEUTICALS ANNOUNCES PRESENTATION OF
POZIOTINIB IN
COMBINATION WITH KRASG12C INHIBITORS AT THE 2021 AACR-NCI-EORTC
CONFERENCE
Source text for Eikon: ID:nBw1wPxCGa
Further company coverage: SPPI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spectrum Pharmaceuticals
See all newsBrief: Assertio Holdings Announces Favorable Vote On Proposed Acquisition Of Spectrum Pharmaceuticals
Brief: Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “For” Proposed Deal With Assertio Holdings, Inc.
Brief: Spectrum Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
Spectrum Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary